NCT00094497 · OUTCOME

Number of Disease-free Patients

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) · Source last updated 2016-09-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: NUMBER
Unit: participants
Interval / dispersion: Not reported
Time frame: every 8 weeks until progression (up to 5 years)

What was measured

complete response or disease-free by time of surgery

Groups in this outcome

EDP-M

etopodide, doxorubicin, cisplatin and mitotane Etoposide Doxorubicin Cisplatin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (Sz-M)

Sz-M

streptozotocin and mitotane Streptozotocin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (EDP-M)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
EDP-M	151
Sz-M	153

Reported measurements

Source class 1

Values in participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
EDP-M	6	Not reported	Not reported	Not reported	Not reported
Sz-M	3	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
6
group Id
OG001
value
3

denoms

counts
group Id
OG000
value
151
group Id
OG001
value
153
units
Participants

description

complete response or disease-free by time of surgery

groups

description
etopodide, doxorubicin, cisplatin and mitotane Etoposide Doxorubicin Cisplatin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (Sz-M)
id
OG000
title
EDP-M
description
streptozotocin and mitotane Streptozotocin Mitotane participants who progressed during first line therapy, were eligible to the alternative treatment (EDP-M)
id
OG001
title
Sz-M

param Type

NUMBER

reporting Status

POSTED

time Frame

every 8 weeks until progression (up to 5 years)

title

Number of Disease-free Patients

type

SECONDARY

unit Of Measure

participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice